Method for treating irritable bowel syndrome by administration of chloride channel opener
AssigneeSucampo AG
InventorsRyuji UENO, Sachiko KUNO
Life of this patent
Estimating the term…
Abstract
A chloride channel opener, especially a prostaglandin compound, is used for the treatment of functional gastrointestinal disorders. The prostaglandin compound can be, for example, a 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E1 compound or 13,14-dihydro-15-keto-16,16-difluoro-18-methyl-prostaglandin E1 compound. The functional gastrointestinal disorders can be, for example, irritable bowel syndrome and/or functional dyspepsia. The treatment can include, for example, systemic administration 1-4 times per day or continuous administration of the compound in an amount of 0.01-100 μg per day.
Claims16
A method for treating irritable bowel syndrome in a mammalian subject, which comprises administration of an effective amount of a chloride channel opener to the subject.
Dependencies are inferred from the claim text.